CMS is sending a message that all prescribers must begin using electronic tools to increase safety and reduce costs. Commerical payers are onboard.
Outgoing HHS Secretary Mike Leavitt calls e-prescribing an "economic imperative" and says that Medicare is expected to save up to $156 million over five years by preventing some 530,000 adverse drug events. Will the new law serve as a bellwether for e-prescribing and help the technology turn the corner, not just for Medicare but also in the commercial environment?
"CMS is sending a message that it wants all stakeholders to pay attention to e-prescribing immediately," says Kathy Roe, partner, health law practice for Neal, Gerber and Eisenberg in Chicago. "It's the right thing to do and can serve as the first step for addressing spiraling healthcare costs. CMS is intent upon offering incentives despite the state of the economy."
Richard Popiel, MD, chief medical officer for Horizon Blue Cross Blue Shield of New Jersey, sees the law as an empowerment tool for the adoption of e-prescribing. With more than 1,500 physicians in the Horizon network, there are 1,000 active e-prescribers. Dr. Popiel says that the insurer initiated an e-prescribing program in 2001. It offers incentives based on the percentage of total scripts that are written electronically to prevent an excess of overall prescriptions.
States are exploring some collaborative initiatives, often supported by managed care insurers.
Florida established ePrescribe Florida, which supports the adoption of e-prescribing by physicians with incentives from health plans and the state to cover financial outlays.
"The CMS ruling should get the attention of physicians," says Ashley Allen, director of health information technology for Blue Cross and Blue Shield of Florida. "For those sitting on the fence, the incentives should help them jump the hurdle."
Allen says the Florida model could likely be applied in other states.
Southeast Michigan created the ePrescribe Initiative, which enables physicians to write prescriptions on a desktop computer or hand-held device, transmit to dispensing pharmacies and have real-time access to patient's eligibility, formulary, drug-fill history, allergies and drug interactions.
The first-year implementation costs approximately $2,000 per physician with ongoing costs of $500 to $600 per year. The Southeast Michigan Initiative offers a total incentive of $1,000-the first $500 after the 10th e-prescription and another $500 after 20 prescriptions per month for six months. From January 2005 to April 2008, 4.5 million prescriptions were sent electronically.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More